NCT03930498 2025-01-28
Programmed Death-1 (PD-1) Antibody Combined With Chemoradiotherapy in High-risk Recurrent Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 2 Active not recruiting
Clinical Trials
9 trialsNCT05011227 2024-03-06
Camrelizumab and Chemotherapy Combined With Endoscopic Surgery for Recurrent Nasopharyngeal Carcinoma
Eye & ENT Hospital of Fudan University
Phase 2 Recruiting
NCT04813705 2023-02-21
18F-FDG PET/CT Guided Reduced-dose Radiotherapy for Nasopharyngeal Carcinoma
Taizhou Hospital
Phase 2 Recruiting
NCT05549466 2023-02-08
Targeted or Chemotherapy Combined With Immunotherapy Versus Chemotherapy for PD-1 Inhibitor Refractory R/M NPC
Sun Yat-sen University
Phase 2 Unknown
NCT05350891 2022-05-10
Transnasal Endoscopic Surgery Combined With Adjuvant Immunotherapy for Recurrent NPC
Eye & ENT Hospital of Fudan University
Phase 2 Recruiting
NCT04447326 2020-06-25
Toripalimab, Endostar Combined With Radiotherapy and Chemotherapy for Nasopharyngeal Carcinoma
First Affiliated Hospital of Guangxi Medical University
Phase 2 Not yet recruiting
NCT04319471 2020-03-24
Sufficient Chemotherapy Combine With Maintenance Chemotherapy in the Treatment of Oligometastatic Nasopharyngeal Carcinoma
Fujian Cancer Hospital
Phase 2 Unknown
NCT03923842 2020-02-17
Dern
Gruppo Oncologico del Nord-Ovest
Phase 2 Unknown
NCT03020329 2019-08-07
Induction Chemotherapy in Young Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 2 Unknown